Atai Life Sciences Market Cap 2020-2024 | ATAI

Atai Life Sciences market cap history and chart from 2020 to 2024. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Atai Life Sciences market cap as of November 07, 2024 is $0.23B.
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.227B $0.000B
atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $20.553B 12.43
Quest Diagnostics (DGX) United States $17.434B 17.67
DaVita (DVA) United States $12.330B 15.95
Encompass Health (EHC) United States $10.431B 24.59
Chemed (CHE) United States $8.349B 25.66
Elanco Animal Health (ELAN) United States $7.168B 17.06
RadNet (RDNT) United States $5.281B 125.26
Option Care Health (OPCH) United States $3.902B 18.49
Amedisys (AMED) United States $3.169B 22.56
LifeStance Health (LFST) United States $2.939B 0.00
Astrana Health (ASTH) United States $2.900B 45.45
Addus HomeCare (ADUS) United States $2.341B 27.46
U.S Physical Therapy (USPH) United States $1.436B 37.81
Pennant (PNTG) United States $1.099B 44.44
Aveanna Healthcare Holdings (AVAH) United States $1.080B 0.00
Daxor (DXR) United States $0.045B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.014B 0.00
Psychemedics (PMD) United States $0.014B 0.00
ATI Physical Therapy (ATIP) United States $0.013B 0.00
Ontrak (OTRK) United States $0.008B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00